Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS Blood and Transplant · Body governed by public law
- Supplier
- bioMerieux UK Ltd
- Value
- £47,085,000
- Procedure
- Open procedure
- Sector
- Software & information systems · Automation system (CPV 48921000)
- Region
- South West
- Official notice
- 035879-2023 on Find a Tender
- Timeline
-
- Contract date4 Dec 2023
- Published6 Dec 2023Published 2 days after the contract date
Description
A direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated solution, which includes all the necessary equipment, installation, maintenance, consumables, reagents, software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below. All invitro diagnostic medical devices, for example, instruments, consumables, and reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended. The end-to-end solution must be capable of producing test results in a format that can be utilised by NHSBT’s host IT system (PULSE) without the need for changes to PULSE.<br/><br/>A fully integrated, high throughput, automated bacterial screening sys…
About the supplier
bioMerieux UK Ltd: every public contract they have won, plus their Companies House record (company 01061914).